| Posts by tnsaf |
| Message | Subject | Recs | Posted |
| albeit more theoretical than practical to dateIt has not worked very well for I | Biotech Valuation | | June 6 |
HALO +18%: fueled by ASCO  | biotech fireworks | | May 17 |
| SRPT -15% at day's low, closed -13% Tue Apr 16, 2013 9:32am EDT (Reuters) - | biotech firesales | | April 17 |
| PolyMedix Announces Results of Special Meeting, Effective Date of Reverse Stock | PolyMedix | | March 20 |
| PolyMedix plans reverse stock split PolyMedix has called a special meeting of i | PolyMedix | | March 7 |
| PolyMedix Announces Proposed Public Offering of Common Stock RADNOR, Pa., Marc | PolyMedix | | March 7 |
| VX-787 Showed Significant Antiviral Activity and Reduced the Severity and Durati | Vertex Pharmaceuticals (VRTX) | | March 7 |
| PolyMedix Provides Business Update and Reports Fourth Quarter 2012 Financial Res | PolyMedix | | March 6 |
| Aveo Pharmaceuticals' NDA for tivozanib to be reviewed by FDA on May 2 AVEO | AVEO Pharmaceuticals | | February 27 |
| PolyMedix CEO Posts Letter to Shareholders on Its Website RADNOR, Pa., Feb. 7, | PolyMedix | | February 13 |
| PolyMedix Announces Departure of CEO, Appointment of Interim CEO RADNOR, Pa., | PolyMedix | | February 5 |
| PolyMedix Engages Investment Banker, Amends Credit Facility RADNOR, Pa., Jan. 2 | PolyMedix | | January 24 |
| mild cases of flu are hitting those with the shot What is the severity for those | Biotech Valuation | | January 9 |
| Synthetic human feces Researchers at the University of Guelph believe they’ve gi | Biotech News | | January 9 |
| >>How come with all that's happened with AFFY there isn't ANY acti | AFFYMETRIX (AFFX) | | January 4 |
| Ohad Hammer offers his Biotech portfolio update: summary for 2012 and 2013 outlo | Biotech Valuation | | 12/24/2012 |
| Cancer cells hide by going dormant, Princess Margaret study finds [Could these | Indications -- Cancer | | 12/17/2012 |
| CRME +40% Cardiome Pharma Corp. ( CRME) ( COM.TO) today announced that the compa | biotech fireworks | | 12/12/2012 |
| Merck withdraws EU cancer drug applicationMerck withdraws European Union applica | ARIAD Pharmaceuticals | | 12/1/2012 |
| Microparticles bearing encephalitogenic peptides induce T-cell tolerance and am | Indications - Neurodegenerative | | 11/25/2012 |
| Not biotech, but interesting tech: Next Generation: Ear-Powered Batteries Devic | Biotech News | | 11/17/2012 |
| PolyMedix Announces Successful Meeting With FDA for Brilacidin Meeting With FDA | PolyMedix | | 11/16/2012 |
| Vertex Presents New Phase 3 Data that Showed People with Hepatitis C Treated wit | Vertex Pharmaceuticals (VRTX) | | 11/10/2012 |
| Data from Viral Kinetic Study Showed Rapid Reduction of HCV RNA with ALS-2200 (V | Vertex Pharmaceuticals (VRTX) | | 11/10/2012 |
| PolyMedix Reports Third Quarter 2012 Financial Results RADNOR, Pa., Nov. 8, 20 | PolyMedix | | 11/9/2012 |
| BioMarin jumped 31 percent to $49.07 in New York, its highest price since the sh | biotech fireworks | | 11/5/2012 |
| PCYC -15% on 3 x average daily volume so far | biotech firesales | | 11/5/2012 |
| BSDM: there are no dollar amounts in their announcement. Did they make $100 last | biotech fireworks | | 10/10/2012 |
| Watch the bouncing cat: PPHM +60% at high, closed +49% on 10 x ADV. And the lega | biotech fireworks | | 9/25/2012 |
| Vertex Announces New Data on ALS-2200 in People With Hepatitis C, Supporting Adv | Vertex Pharmaceuticals (VRTX) | | 9/25/2012 |
| Halozyme soars 27% on Cinryze drug update By Val Brickates Kennedy Sept. 21, 20 | biotech fireworks | | 9/21/2012 |
| PolyMedix Receives Grant From National Cancer Institute to Study Brilacidin for | PolyMedix | | 9/20/2012 |
| PolyMedix Presents New Data on Its Defensin-Mimetic Antibiotics at 52nd Annual I | PolyMedix | | 9/12/2012 |
| Seattle Genetics: Positive Read-Through From Roche's Investor Day A Seeking | Seattle Genetics (SGEN) | | 9/12/2012 |
| PolyCides Outperformed Triclosan as Active Antimicrobial Agent in Suture Coating | PolyMedix | | 9/5/2012 |
| Vertex Announces Appointment of Stuart A. Arbuckle as Chief Commercial Officer | Vertex Pharmaceuticals (VRTX) | | 9/4/2012 |
| CPRX -27% at bottom, currently -20% Catalyst Pharmaceutical Partners, Inc. Ra | biotech firesales | | 8/28/2012 |
| Jakavi® (ruxolitinib) First Medication to Receive European Commission Appro | Incyte Pharmaceuticals (INCY) | | 8/28/2012 |
| FDA Reviews the Use of Progression-Free Survival in Cancer Trials medscape.com& | Biotech News | | 8/24/2012 |
| Ian, that method of restoring vision resembles one of the themes in Robert Sawye | Biotech Valuation | | 8/14/2012 |
| PolyMedix Reports Second Quarter 2012 Financial Results RADNOR, Pa., Aug. 9, 2 | PolyMedix | | 8/12/2012 |
| HALO +25%; management must have convinced Q2-conference-call listeners that the | biotech fireworks | | 8/7/2012 |
| New Data Confirm Safety of Stopping Imatinib in LeukemiaI MNG Medical Media. 201 | Indications -- Cancer | | 8/7/2012 |
| halo +17% at high, currently +13%; bounced off the bottom of the cliff | biotech fireworks | | 8/3/2012 |
| ARRY -17% on results of ARRY-797 study | biotech firesales | | 8/1/2012 |
| PolyMedix and University of Pennsylvania Collaborate to Develop New Class of Def | PolyMedix | | 7/31/2012 |
| You are invited to participate in: Vertex Pharmaceuticals Incorporated Second Q | Vertex Pharmaceuticals (VRTX) | | 7/18/2012 |
| VVUS is having a wild ride on PDUFA day: -27% at one point now -9%; volume is al | biotech firesales | | 7/17/2012 |
| VRTX -21% at low, closed -16% on news: Link: SI Message 28235649 | biotech firesales | | 6/29/2012 |
| Vertex shares fall as investors doubt drug data By Toni Clarke and Bill Berkr | Vertex Pharmaceuticals (VRTX) | | 6/29/2012 |
Copyright © 1995-2013 Knight Sac Media. All rights reserved.
